You are here

AusPAR: Ranibizumab

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

9 December 2014
AusPAR Details
AusPAR
Active Ingredient
Ranibizumab
Product Name
Lucentis
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Submission Number
PM-2013-00985-1-5
Submission Type
Extension of indications
Decision
Approved
AusPAR Date
14 October 2014
Publication Date

9 December 2014